The effect of fresh human serum on ofloxacin bactericidal activity. 1990

A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
2nd Dept. of Infectious Diseases, University of Genoa, G. Gaslini Institute, Italy.

We have studied the possibility of an increase in ofloxacin bactericidal activity when it is combined with fresh human serum. The tested strains were 10 clinical isolates of Klebsiella pneumoniae. From among our strains 5 were susceptible to serum bactericidal activity and 5 were found to be resistant. We selected two serum concentrations (15 and 35%) to test against susceptible strains and two (55 and 75%) to test against resistant strains in combination with the minimum inhibitory concentration (MIC), 1/2MIC and 1/4MIC of ofloxacin. The results show a slight variability among the tested strains depending on microbiological characteristics of single strains, however, the serum + ofloxacin combination was advantageous. Only one exception was observed: a resistant strain that had an increased survival percentage against ofloxacin and serum in combination.

UI MeSH Term Description Entries
D007711 Klebsiella pneumoniae Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans. Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280

Related Publications

A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
February 1987, European journal of clinical microbiology,
A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
October 1969, The Yale journal of biology and medicine,
A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
July 1989, Journal of chemotherapy (Florence, Italy),
A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
November 1990, Kekkaku : [Tuberculosis],
A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
January 1994, The Journal of antimicrobial chemotherapy,
A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
February 1982, The Journal of antimicrobial chemotherapy,
A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
January 1966, Antimicrobial agents and chemotherapy,
A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
January 1987, Microbiology and immunology,
A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
February 1992, Journal of immunology (Baltimore, Md. : 1950),
A Fabbri, and A Tacchella, and E Ugolotti, and M L Belli, and T Vittorino, and A Campelli
November 1985, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
Copied contents to your clipboard!